Cyltezo Purple Book BLA 761058
- BLA number
- 761058
- Proprietary names
- Cyltezo
- Proper names
- adalimumab-adbm
- Applicant
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Center
- CDER
- First observed release
- 2020-02-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | 40MG/0.8ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2017-08-25 | |
| 002 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | 20MG/0.4ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2018-07-13 | |
| 003 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | 10MG/0.2ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2022-03-18 | |
| 004 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | 40MG/0.8ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2023-05-18 | |
| 005 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | 40MG/0.4ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | Licensed | 2024-04-30 | |
| 006 | Cyltezo | adalimumab-adbm | 351(k) Interchangeable | 40MG/0.4ML | Injection | Subcutaneous | Autoinjector | Rx | Licensed | 2024-04-30 | |
Reference Biological Product#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125057 | Humira | adalimumab | 351(a) | Rx | 2026-06-01 |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2025-05-01 | U | 005 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2025-05-01 | U | 006 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2024-05-01 | N | 005 | Cyltezo | 351(k) Biosimilar | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2024-05-01 | N | 006 | Cyltezo | 351(k) Biosimilar | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2023-10-01 | U | 001 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2023-10-01 | U | 002 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2023-10-01 | U | 003 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2023-10-01 | U | 004 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2023-06-01 | U | 004 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2022-05-01 | U | 003 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2021-10-01 | U | 001 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2021-10-01 | U | 002 | Cyltezo | 351(k) Interchangeable | Rx | Boehringer Ingelheim Pharmaceuticals, Inc. |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2025-05-01 | 005 | Cyltezo | 351(k) Interchangeable | Rx | Licensed | 2024-04-30 |
| 2025-05-01 | 006 | Cyltezo | 351(k) Interchangeable | Rx | Licensed | 2024-04-30 |
| 2024-05-01 | 005 | Cyltezo | 351(k) Biosimilar | Rx | Licensed | 2024-04-30 |
| 2024-05-01 | 006 | Cyltezo | 351(k) Biosimilar | Rx | Licensed | 2024-04-30 |
| 2023-06-01 | 004 | Cyltezo | 351(k) Interchangeable | Rx | Licensed | 2023-05-18 |
| 2022-05-01 | 003 | Cyltezo | 351(k) Interchangeable | Rx | Licensed | 2022-03-18 |
| 2021-10-01 | 001 | Cyltezo | 351(k) Interchangeable | Rx | Licensed | 2017-08-25 |
| 2021-10-01 | 002 | Cyltezo | 351(k) Interchangeable | Rx | Licensed | 2018-07-13 |
| 2020-05-01 | 001 | Cyltezo | 351(k) Biosimilar | Rx | Licensed | 2017-08-25 |
| 2020-05-01 | 002 | Cyltezo | 351(k) Biosimilar | Rx | Licensed | 2018-07-13 |
| 2020-02-01 | 001 | Cyltezo | 351(k) Biosimilar | Marketed | Licensed | 2017-08-25 |
| 2020-02-01 | 002 | Cyltezo | 351(k) Biosimilar | Marketed | Licensed | 2018-07-13 |